Global Hepatitis Drugs Market Insights, Forecast to 2029

Global Hepatitis Drugs Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Hepatitis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 VEMLIDY
1.2.3 EPCLUSA
1.2.4 SOVALDI
1.2.5 INCIVEK
1.2.6 OLYSIO
1.2.7 VICTRELIS
1.2.8 VIREAD
1.2.9 HEPSERA
1.2.10 BARACLUDE
1.2.11 TYZEKA
1.3 Market by Application
1.3.1 Global Hepatitis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hepatitis A
1.3.3 Hepatitis B
1.3.4 Hepatitis C
1.3.5 Hepatitis D
1.3.6 Hepatitis E
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hepatitis Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Hepatitis Drugs Revenue by Region
2.2.1 Global Hepatitis Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hepatitis Drugs Revenue by Region (2018-2023)
2.2.3 Global Hepatitis Drugs Revenue by Region (2024-2029)
2.2.4 Global Hepatitis Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Hepatitis Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Hepatitis Drugs Sales by Region
2.4.1 Global Hepatitis Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hepatitis Drugs Sales by Region (2018-2023)
2.4.3 Global Hepatitis Drugs Sales by Region (2024-2029)
2.4.4 Global Hepatitis Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Hepatitis Drugs Sales by Manufacturers
3.1.1 Global Hepatitis Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Hepatitis Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis Drugs in 2022
3.2 Global Hepatitis Drugs Revenue by Manufacturers
3.2.1 Global Hepatitis Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Hepatitis Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis Drugs Revenue in 2022
3.3 Global Key Players of Hepatitis Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Hepatitis Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hepatitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hepatitis Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hepatitis Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Hepatitis Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis Drugs Sales by Type
4.1.1 Global Hepatitis Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Hepatitis Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Hepatitis Drugs Sales Market Share by Type (2018-2029)
4.2 Global Hepatitis Drugs Revenue by Type
4.2.1 Global Hepatitis Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Hepatitis Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hepatitis Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Hepatitis Drugs Price by Type
4.3.1 Global Hepatitis Drugs Price by Type (2018-2023)
4.3.2 Global Hepatitis Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Hepatitis Drugs Sales by Application
5.1.1 Global Hepatitis Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Hepatitis Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Hepatitis Drugs Sales Market Share by Application (2018-2029)
5.2 Global Hepatitis Drugs Revenue by Application
5.2.1 Global Hepatitis Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Hepatitis Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hepatitis Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Hepatitis Drugs Price by Application
5.3.1 Global Hepatitis Drugs Price by Application (2018-2023)
5.3.2 Global Hepatitis Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Hepatitis Drugs Market Size by Type
6.1.1 US & Canada Hepatitis Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Hepatitis Drugs Revenue by Type (2018-2029)
6.2 US & Canada Hepatitis Drugs Market Size by Application
6.2.1 US & Canada Hepatitis Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Hepatitis Drugs Revenue by Application (2018-2029)
6.3 US & Canada Hepatitis Drugs Market Size by Country
6.3.1 US & Canada Hepatitis Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hepatitis Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Hepatitis Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Hepatitis Drugs Market Size by Type
7.1.1 Europe Hepatitis Drugs Sales by Type (2018-2029)
7.1.2 Europe Hepatitis Drugs Revenue by Type (2018-2029)
7.2 Europe Hepatitis Drugs Market Size by Application
7.2.1 Europe Hepatitis Drugs Sales by Application (2018-2029)
7.2.2 Europe Hepatitis Drugs Revenue by Application (2018-2029)
7.3 Europe Hepatitis Drugs Market Size by Country
7.3.1 Europe Hepatitis Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hepatitis Drugs Sales by Country (2018-2029)
7.3.3 Europe Hepatitis Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Hepatitis Drugs Market Size
8.1.1 China Hepatitis Drugs Sales (2018-2029)
8.1.2 China Hepatitis Drugs Revenue (2018-2029)
8.2 China Hepatitis Drugs Market Size by Application
8.2.1 China Hepatitis Drugs Sales by Application (2018-2029)
8.2.2 China Hepatitis Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hepatitis Drugs Market Size by Type
9.1.1 Asia Hepatitis Drugs Sales by Type (2018-2029)
9.1.2 Asia Hepatitis Drugs Revenue by Type (2018-2029)
9.2 Asia Hepatitis Drugs Market Size by Application
9.2.1 Asia Hepatitis Drugs Sales by Application (2018-2029)
9.2.2 Asia Hepatitis Drugs Revenue by Application (2018-2029)
9.3 Asia Hepatitis Drugs Sales by Region
9.3.1 Asia Hepatitis Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hepatitis Drugs Revenue by Region (2018-2029)
9.3.3 Asia Hepatitis Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hepatitis Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Hepatitis Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hepatitis Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hepatitis Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Hepatitis Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hepatitis Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hepatitis Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Hepatitis Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hepatitis Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hepatitis Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 F. Hoffmann-La Roche Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Gilead Sciences Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GlaxoSmithKline Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Johnson & Johnson Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Merck Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Novartis Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Information
11.7.2 Vertex Pharmaceuticals Overview
11.7.3 Vertex Pharmaceuticals Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Vertex Pharmaceuticals Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Vertex Pharmaceuticals Recent Developments
11.8 Abbvie
11.8.1 Abbvie Company Information
11.8.2 Abbvie Overview
11.8.3 Abbvie Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Abbvie Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbvie Recent Developments
11.9 Achillion Pharmaceuticals
11.9.1 Achillion Pharmaceuticals Company Information
11.9.2 Achillion Pharmaceuticals Overview
11.9.3 Achillion Pharmaceuticals Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Achillion Pharmaceuticals Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Achillion Pharmaceuticals Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb Hepatitis Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Bristol-Myers Squibb Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol-Myers Squibb Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis Drugs Industry Chain Analysis
12.2 Hepatitis Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis Drugs Production Mode & Process
12.4 Hepatitis Drugs Sales and Marketing
12.4.1 Hepatitis Drugs Sales Channels
12.4.2 Hepatitis Drugs Distributors
12.5 Hepatitis Drugs Customers
13 Market Dynamics
13.1 Hepatitis Drugs Industry Trends
13.2 Hepatitis Drugs Market Drivers
13.3 Hepatitis Drugs Market Challenges
13.4 Hepatitis Drugs Market Restraints
14 Key Findings in The Global Hepatitis Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hepatitis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of VEMLIDY
Table 3. Major Manufacturers of EPCLUSA
Table 4. Major Manufacturers of SOVALDI
Table 5. Major Manufacturers of INCIVEK
Table 6. Major Manufacturers of OLYSIO
Table 7. Major Manufacturers of VICTRELIS
Table 8. Major Manufacturers of VIREAD
Table 9. Major Manufacturers of HEPSERA
Table 10. Major Manufacturers of BARACLUDE
Table 11. Major Manufacturers of TYZEKA
Table 12. Global Hepatitis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Hepatitis Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Hepatitis Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 15. Global Hepatitis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 16. Global Hepatitis Drugs Revenue Market Share by Region (2018-2023)
Table 17. Global Hepatitis Drugs Revenue Market Share by Region (2024-2029)
Table 18. Global Hepatitis Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 19. Global Hepatitis Drugs Sales by Region (2018-2023) & (K Units)
Table 20. Global Hepatitis Drugs Sales by Region (2024-2029) & (K Units)
Table 21. Global Hepatitis Drugs Sales Market Share by Region (2018-2023)
Table 22. Global Hepatitis Drugs Sales Market Share by Region (2024-2029)
Table 23. Global Hepatitis Drugs Sales by Manufacturers (2018-2023) & (K Units)
Table 24. Global Hepatitis Drugs Sales Share by Manufacturers (2018-2023)
Table 25. Global Hepatitis Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 26. Global Hepatitis Drugs Revenue Share by Manufacturers (2018-2023)
Table 27. Global Key Players of Hepatitis Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 28. Hepatitis Drugs Price by Manufacturers 2018-2023 (USD/Unit)
Table 29. Global Hepatitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Hepatitis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Drugs as of 2022)
Table 31. Global Key Manufacturers of Hepatitis Drugs, Manufacturing Base Distribution and Headquarters
Table 32. Global Key Manufacturers of Hepatitis Drugs, Product Offered and Application
Table 33. Global Key Manufacturers of Hepatitis Drugs, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hepatitis Drugs Sales by Type (2018-2023) & (K Units)
Table 36. Global Hepatitis Drugs Sales by Type (2024-2029) & (K Units)
Table 37. Global Hepatitis Drugs Sales Share by Type (2018-2023)
Table 38. Global Hepatitis Drugs Sales Share by Type (2024-2029)
Table 39. Global Hepatitis Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 40. Global Hepatitis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 41. Global Hepatitis Drugs Revenue Share by Type (2018-2023)
Table 42. Global Hepatitis Drugs Revenue Share by Type (2024-2029)
Table 43. Hepatitis Drugs Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Hepatitis Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 45. Global Hepatitis Drugs Sales by Application (2018-2023) & (K Units)
Table 46. Global Hepatitis Drugs Sales by Application (2024-2029) & (K Units)
Table 47. Global Hepatitis Drugs Sales Share by Application (2018-2023)
Table 48. Global Hepatitis Drugs Sales Share by Application (2024-2029)
Table 49. Global Hepatitis Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 50. Global Hepatitis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 51. Global Hepatitis Drugs Revenue Share by Application (2018-2023)
Table 52. Global Hepatitis Drugs Revenue Share by Application (2024-2029)
Table 53. Hepatitis Drugs Price by Application (2018-2023) & (USD/Unit)
Table 54. Global Hepatitis Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 55. US & Canada Hepatitis Drugs Sales by Type (2018-2023) & (K Units)
Table 56. US & Canada Hepatitis Drugs Sales by Type (2024-2029) & (K Units)
Table 57. US & Canada Hepatitis Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 58. US & Canada Hepatitis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 59. US & Canada Hepatitis Drugs Sales by Application (2018-2023) & (K Units)
Table 60. US & Canada Hepatitis Drugs Sales by Application (2024-2029) & (K Units)
Table 61. US & Canada Hepatitis Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 62. US & Canada Hepatitis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 63. US & Canada Hepatitis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 64. US & Canada Hepatitis Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 65. US & Canada Hepatitis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 66. US & Canada Hepatitis Drugs Sales by Country (2018-2023) & (K Units)
Table 67. US & Canada Hepatitis Drugs Sales by Country (2024-2029) & (K Units)
Table 68. Europe Hepatitis Drugs Sales by Type (2018-2023) & (K Units)
Table 69. Europe Hepatitis Drugs Sales by Type (2024-2029) & (K Units)
Table 70. Europe Hepatitis Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Hepatitis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 72. Europe Hepatitis Drugs Sales by Application (2018-2023) & (K Units)
Table 73. Europe Hepatitis Drugs Sales by Application (2024-2029) & (K Units)
Table 74. Europe Hepatitis Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Hepatitis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 76. Europe Hepatitis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 77. Europe Hepatitis Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Hepatitis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 79. Europe Hepatitis Drugs Sales by Country (2018-2023) & (K Units)
Table 80. Europe Hepatitis Drugs Sales by Country (2024-2029) & (K Units)
Table 81. China Hepatitis Drugs Sales by Type (2018-2023) & (K Units)
Table 82. China Hepatitis Drugs Sales by Type (2024-2029) & (K Units)
Table 83. China Hepatitis Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Hepatitis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. China Hepatitis Drugs Sales by Application (2018-2023) & (K Units)
Table 86. China Hepatitis Drugs Sales by Application (2024-2029) & (K Units)
Table 87. China Hepatitis Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Hepatitis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Hepatitis Drugs Sales by Type (2018-2023) & (K Units)
Table 90. Asia Hepatitis Drugs Sales by Type (2024-2029) & (K Units)
Table 91. Asia Hepatitis Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 92. Asia Hepatitis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 93. Asia Hepatitis Drugs Sales by Application (2018-2023) & (K Units)
Table 94. Asia Hepatitis Drugs Sales by Application (2024-2029) & (K Units)
Table 95. Asia Hepatitis Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 96. Asia Hepatitis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 97. Asia Hepatitis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. Asia Hepatitis Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 99. Asia Hepatitis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 100. Asia Hepatitis Drugs Sales by Region (2018-2023) & (K Units)
Table 101. Asia Hepatitis Drugs Sales by Region (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Hepatitis Drugs Sales by Type (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Hepatitis Drugs Sales by Type (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Hepatitis Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hepatitis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Hepatitis Drugs Sales by Application (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Hepatitis Drugs Sales by Application (2024-2029) & (K Units)
Table 108. Middle East, Africa and Latin America Hepatitis Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Hepatitis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Hepatitis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East, Africa and Latin America Hepatitis Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Hepatitis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 113. Middle East, Africa and Latin America Hepatitis Drugs Sales by Country (2018-2023) & (K Units)
Table 114. Middle East, Africa and Latin America Hepatitis Drugs Sales by Country (2024-2029) & (K Units)
Table 115. F. Hoffmann-La Roche Company Information
Table 116. F. Hoffmann-La Roche Description and Major Businesses
Table 117. F. Hoffmann-La Roche Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. F. Hoffmann-La Roche Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. F. Hoffmann-La Roche Recent Developments
Table 120. Gilead Sciences Company Information
Table 121. Gilead Sciences Description and Major Businesses
Table 122. Gilead Sciences Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Gilead Sciences Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Gilead Sciences Recent Developments
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Description and Major Businesses
Table 127. GlaxoSmithKline Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. GlaxoSmithKline Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GlaxoSmithKline Recent Developments
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Description and Major Businesses
Table 132. Johnson & Johnson Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Johnson & Johnson Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Johnson & Johnson Recent Developments
Table 135. Merck Company Information
Table 136. Merck Description and Major Businesses
Table 137. Merck Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Merck Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Merck Recent Developments
Table 140. Novartis Company Information
Table 141. Novartis Description and Major Businesses
Table 142. Novartis Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Novartis Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Novartis Recent Developments
Table 145. Vertex Pharmaceuticals Company Information
Table 146. Vertex Pharmaceuticals Description and Major Businesses
Table 147. Vertex Pharmaceuticals Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Vertex Pharmaceuticals Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Vertex Pharmaceuticals Recent Developments
Table 150. Abbvie Company Information
Table 151. Abbvie Description and Major Businesses
Table 152. Abbvie Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Abbvie Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Abbvie Recent Developments
Table 155. Achillion Pharmaceuticals Company Information
Table 156. Achillion Pharmaceuticals Description and Major Businesses
Table 157. Achillion Pharmaceuticals Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Achillion Pharmaceuticals Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Achillion Pharmaceuticals Recent Developments
Table 160. Bristol-Myers Squibb Company Information
Table 161. Bristol-Myers Squibb Description and Major Businesses
Table 162. Bristol-Myers Squibb Hepatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Bristol-Myers Squibb Hepatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Bristol-Myers Squibb Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Hepatitis Drugs Distributors List
Table 168. Hepatitis Drugs Customers List
Table 169. Hepatitis Drugs Market Trends
Table 170. Hepatitis Drugs Market Drivers
Table 171. Hepatitis Drugs Market Challenges
Table 172. Hepatitis Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis Drugs Product Picture
Figure 2. Global Hepatitis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hepatitis Drugs Market Share by Type in 2022 & 2029
Figure 4. VEMLIDY Product Picture
Figure 5. EPCLUSA Product Picture
Figure 6. SOVALDI Product Picture
Figure 7. INCIVEK Product Picture
Figure 8. OLYSIO Product Picture
Figure 9. VICTRELIS Product Picture
Figure 10. VIREAD Product Picture
Figure 11. HEPSERA Product Picture
Figure 12. BARACLUDE Product Picture
Figure 13. TYZEKA Product Picture
Figure 14. Global Hepatitis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 15. Global Hepatitis Drugs Market Share by Application in 2022 & 2029
Figure 16. Hepatitis A
Figure 17. Hepatitis B
Figure 18. Hepatitis C
Figure 19. Hepatitis D
Figure 20. Hepatitis E
Figure 21. Hepatitis Drugs Report Years Considered
Figure 22. Global Hepatitis Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 23. Global Hepatitis Drugs Revenue 2018-2029 (US$ Million)
Figure 24. Global Hepatitis Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 25. Global Hepatitis Drugs Revenue Market Share by Region (2018-2029)
Figure 26. Global Hepatitis Drugs Sales 2018-2029 ((K Units)
Figure 27. Global Hepatitis Drugs Sales Market Share by Region (2018-2029)
Figure 28. US & Canada Hepatitis Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. US & Canada Hepatitis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Europe Hepatitis Drugs Sales YoY (2018-2029) & (K Units)
Figure 31. Europe Hepatitis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. China Hepatitis Drugs Sales YoY (2018-2029) & (K Units)
Figure 33. China Hepatitis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 34. Asia (excluding China) Hepatitis Drugs Sales YoY (2018-2029) & (K Units)
Figure 35. Asia (excluding China) Hepatitis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 36. Middle East, Africa and Latin America Hepatitis Drugs Sales YoY (2018-2029) & (K Units)
Figure 37. Middle East, Africa and Latin America Hepatitis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 38. The Hepatitis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 39. The Top 5 and 10 Largest Manufacturers of Hepatitis Drugs in the World: Market Share by Hepatitis Drugs Revenue in 2022
Figure 40. Global Hepatitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 41. Global Hepatitis Drugs Sales Market Share by Type (2018-2029)
Figure 42. Global Hepatitis Drugs Revenue Market Share by Type (2018-2029)
Figure 43. Global Hepatitis Drugs Sales Market Share by Application (2018-2029)
Figure 44. Global Hepatitis Drugs Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada Hepatitis Drugs Sales Market Share by Type (2018-2029)
Figure 46. US & Canada Hepatitis Drugs Revenue Market Share by Type (2018-2029)
Figure 47. US & Canada Hepatitis Drugs Sales Market Share by Application (2018-2029)
Figure 48. US & Canada Hepatitis Drugs Revenue Market Share by Application (2018-2029)
Figure 49. US & Canada Hepatitis Drugs Revenue Share by Country (2018-2029)
Figure 50. US & Canada Hepatitis Drugs Sales Share by Country (2018-2029)
Figure 51. U.S. Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Canada Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Europe Hepatitis Drugs Sales Market Share by Type (2018-2029)
Figure 54. Europe Hepatitis Drugs Revenue Market Share by Type (2018-2029)
Figure 55. Europe Hepatitis Drugs Sales Market Share by Application (2018-2029)
Figure 56. Europe Hepatitis Drugs Revenue Market Share by Application (2018-2029)
Figure 57. Europe Hepatitis Drugs Revenue Share by Country (2018-2029)
Figure 58. Europe Hepatitis Drugs Sales Share by Country (2018-2029)
Figure 59. Germany Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 60. France Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 61. U.K. Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 62. Italy Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 63. Russia Hepatitis Drugs Revenue (2018-2029) & (US$ Million)
Figure 64. China Hepatitis Drugs Sales Market Share by Type (2018-2029)
Figure 65. China Hepatitis Drugs Revenue Market Share by Type (2018-2029)
Figure 66. China Hepatitis Drugs Sales Market Share by Application (2018-2029)
Figure 67. China Hepatitis Drugs Revenue Market Share by Application (2018-2029)
Figure 68. Asia Hepatitis Drugs Sales Market Share by Type (2018-2029)
Figure 69. Asia Hepatitis Drugs Revenue Market Share by Type (2018-2029)
Figure 70. Asia Hepatitis Drugs Sale

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hepatitis A Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89

According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......

Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......

Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......

Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Thymosin a1 Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Hepatitis B Immune Globulin Market Research Report 2023

Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......

Global Sofosbuvir Market Research Report 2023

Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......

Global Hepatitis A Vaccine Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs